Cargando…

Progress of Diabetic Macular Edema after Loading Injection of Anti-Vascular Endothelial Growth Factor Agents in Real-World Cases

Background and Objectives: To evaluate the recurrence of diabetic macular edema (DME) after loading an injection of anti-VEGF agents by a pro re nata (PRN) protocol using central retinal thickness (CRT) as a re-injection criterion. Materials and Methods: This is a retrospective, observational single...

Descripción completa

Detalles Bibliográficos
Autores principales:	Enomoto, Hiroko, Sugimoto, Masahiko, Asami, Shin, Kondo, Mineo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610068/ https://www.ncbi.nlm.nih.gov/pubmed/36295479 http://dx.doi.org/10.3390/medicina58101318

Ejemplares similares

Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema in Eyes with Branch Retinal Vein Occlusion with vs Without Glaucoma – Does Glaucoma Affect Visual Outcome in Eyes with BRVO-ME After antiVEGF Injections?
por: Asami, Shin, et al.
Publicado: (2022)

Intravitreal aflibercept for diabetic macular edema in real-world clinical practice in Japan: 24-month outcomes
por: Sugimoto, Masahiko, et al.
Publicado: (2022)

Correction to: Intravitreal aflibercept for diabetic macular edema in real‑world clinical practice in Japan: 24‑month outcomes
por: Sugimoto, Masahiko, et al.
Publicado: (2022)

Response to Initial Anti-Vascular Endothelial Growth Factor for Diabetic Macular Edema Is Significantly Correlated with Response to Third Consecutive Monthly Injection
por: Maeda, Satoshi, et al.
Publicado: (2022)

Effects of suspension of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration in clinical setting
por: Matsubara, Hisashi, et al.
Publicado: (2022)

Effectiveness of microperimetry in evaluating anti-vascular endothelial growth factor therapy for diabetic macular edema patients with relatively good vision: A retrospective observational study
por: Sugimoto, Masahiko, et al.
Publicado: (2021)

Clinical preferences and trends of anti‐vascular endothelial growth factor treatments for diabetic macular edema in Japan
por: Sugimoto, Masahiko, et al.
Publicado: (2018)

Expression of vascular infarction-related molecules after anti-vascular endothelium growth factor treatment for diabetic macular edema
por: Sugimoto, Masahiko, et al.
Publicado: (2019)

Two year result of intravitreal bevacizumab for diabetic macular edema using treat and extend protocol
por: Sugimoto, Masahiko, et al.
Publicado: (2017)

Treatment of diabetic macular edema in real‐world clinical practice: The effect of aging
por: Kusuhara, Sentaro, et al.
Publicado: (2022)

Importance of Central Retinal Sensitivity for Prediction of Visual Acuity after Intravitreal Bevacizumb in Eyes with Macular Edema Associated with Branch Retinal Vein Occlusion
por: Sugimoto, Masahiko, et al.
Publicado: (2016)

Effects of Intravitreal Aflibercept on Retinal Function and Improvement of Macular Edema Associated With Diabetic Retinopathy
por: Ichio, Atsushi, et al.
Publicado: (2020)

Anti-vascular endothelial growth factor agent reduces inflammation in macular edema with central retinal vein occlusion
por: Mashima, Asako, et al.
Publicado: (2019)

Increased expression of Protein S in eyes with diabetic retinopathy and diabetic macular edema
por: Sugimoto, Masahiko, et al.
Publicado: (2021)

Reduced Size of Telangiectatic Capillaries After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents in Diabetic Macular Edema
por: Itou, Junichi, et al.
Publicado: (2023)

Real-World Persistence and Treatment Interval in Patients with Diabetic Macular Edema Treated with Anti-Vascular Endothelial Growth Factors in the USA
por: Bakri, Sophie J., et al.
Publicado: (2023)

Commentary: Switching of anti-vascular endothelial growth factor agents in refractory diabetic macular edema
por: Ratra, Dhanashree
Publicado: (2021)

Efficacy of Psychiatric Treatment to Treat a Specific Phobia of Intravitreal Injections in a Patient with Neovascular Age-Related Macular Degeneration
por: Ozaki, Atsuta, et al.
Publicado: (2021)

Real-World Injection Frequency and Cost of Ranibizumab and Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
por: Kiss, Szilárd, et al.
Publicado: (2020)

Effects of Topical or Intravitreal Application of Anti-Vascular Endothelial Growth Factor on Density of Intestinal Blood Vessels of Mice
por: Ichio, Atsushi, et al.
Publicado: (2023)

Identifying Genetic Biomarkers Predicting Response to Anti-Vascular Endothelial Growth Factor Injections in Diabetic Macular Edema
por: Gurung, Rajya L., et al.
Publicado: (2022)

Treatment of Diabetic Macular Edema or Macular Edema Following Retinal Vein Occlusion Based on Repeated Injection of the Dexamethasone Intravitreal Implant: A Retrospective Real-World Analysis
por: Sanders, Francis W B, et al.
Publicado: (2023)

Which Explanatory Variables Contribute to the Classification of Good Visual Acuity over Time in Patients with Branch Retinal Vein Occlusion with Macular Edema Using Machine Learning?
por: Matsui, Yoshitsugu, et al.
Publicado: (2022)

Anti-vascular endothelial growth factor treatment in diabetic macular edema
por: Kim, Moosang
Publicado: (2016)

Comparison of 2-Year Outcomes between Intravitreal Ranibizumab and Intravitreal Aflibercept for Diabetic Macular Edema with “Treat-and-Extend” Regimen—Its Usefulness and Problems
por: Chujo, Shinichiro, et al.
Publicado: (2020)

Modeling Time Effects in Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema – A Mixed Model Analysis of Real-World Data
por: Mylona, Ioanna, et al.
Publicado: (2020)

Regression of macular edema secondary to branch retinal vein occlusion during anti-TNF-α therapy for rheumatoid arthritis
por: Kachi, Shu, et al.
Publicado: (2010)

Evaluation of markers of outcome in real-world treatment of diabetic macular edema
por: Campos, António, et al.
Publicado: (2018)

Anti-vascular endothelial growth factor in the treatment of macular edema in epidemic retinitis
por: Kawali, Ankush A, et al.
Publicado: (2020)

CHANGES IN PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR LEVEL AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB, AFLIBERCEPT, OR RANIBIZUMAB FOR DIABETIC MACULAR EDEMA
por: Hirano, Takao, et al.
Publicado: (2018)

Hemodynamic Effects of Anti-Vascular Endothelial Growth Factor Injections on Optical Coherence Tomography Angiography in Diabetic Macular Edema Eyes
por: Song, Jessica, et al.
Publicado: (2022)

Predictive factors for treatment outcomes with intravitreal anti-vascular endothelial growth factor injections in diabetic macular edema in clinical practice
por: Gurung, Rajya L, et al.
Publicado: (2023)

Real-World Treatment Patterns and Vision Outcomes with Ranibizumab for Diabetic Macular Edema
por: Naujokaitis, Tadas, et al.
Publicado: (2021)

Real-world treatment patterns and economic burden of post-cataract macular edema
por: Ahmadyar, Gina, et al.
Publicado: (2023)

Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema
por: Kiss, Szilárd, et al.
Publicado: (2014)

Real-World Data on Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 24-Month Outcomes
por: Shimura, Masahiko, et al.
Publicado: (2022)

Anti-Vascular Endothelial Growth Factor Therapy with or Without Initial Steroid Therapy for Macular Edema in Branch Retinal Vein Occlusion
por: Noma, Hidetaka, et al.
Publicado: (2023)

Intravitreal injection of Bevacizumab in diabetic macular edema
por: Ateeq, Asim, et al.
Publicado: (2014)

Suspension of Anti-VEGF Treatment Does Not Affect Expansion of RPE Atrophy in Neovascular Age-Related Macular Degeneration
por: Chujo, Shinichiro, et al.
Publicado: (2023)

Clinical Application of Intravitreal Aflibercept Injection for Diabetic Macular Edema Comparing Two Loading Regimens
por: Chung, Yoo-Ri, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m09hpj1ur51r4r05nsl8ttuu5d